Views & Analysis

Market Access
Medicines pricing, UK £20 notes with various pills

Buyer’s remorse: The UK’s VPAG

With the ABPI wanting to change the scheme just over a year into its five-year term, it seems that they have buyer’s remorse.

Market Access
Regulatory compliance checklist

Working in the grey: FDA, CMS and data privacy

For companies in the biotech space, it’s never been easy to navigate the legal and business risks inherent in a highly regulated, dynamic industry – and it’s only becoming more complicated